Hussman Strategic Advisors’s Amgen AMGN Stock Holding History

Hussman Strategic Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Sell	5,250 -3,150	-38%	-$1.12M	0.4%	119
2025 Q4	$2.75M	Buy	+8,400	New	+$2.66M	0.66%	36
2025 Q1	–	Sell	-14,700	Closed	-$3.83M	–	239
2024 Q4	$3.83M	Buy	14,700 +4,200	+40%	+$1.25M	1.13%	9
2024 Q3	$3.38M	Sell	10,500 -2,100	-17%	-$687K	0.83%	22
2024 Q2	$3.94M	Buy	12,600 +2,100	+20%	+$617K	1.08%	6
2024 Q1	$2.99M	Buy	10,500 +4,200	+67%	+$1.23M	0.69%	54
2023 Q4	$1.81M	Sell	6,300 -9,450	-60%	-$2.57M	0.41%	96
2023 Q3	$4.23M	Buy	15,750 +150	+1%	+$37.4K	0.81%	19
2023 Q2	$3.46M	Buy	15,600 +100	+0.6%	+$23.2K	0.64%	27
2023 Q1	$3.75M	Hold	15,500	–	–	0.59%	36
2022 Q4	$4.07M	Sell	15,500 -3,100	-17%	-$831K	0.66%	33
2022 Q3	$4.19M	Buy	18,600 +8,250	+80%	+$2M	0.72%	28
2022 Q2	$2.52M	Buy	10,350 +2,550	+33%	+$625K	0.43%	82
2022 Q1	$1.89M	Sell	7,800 -2,600	-25%	-$597K	0.37%	106
2021 Q4	$2.34M	Buy	10,400 +1,100	+12%	+$232K	0.51%	65
2021 Q3	$1.98M	Hold	9,300	–	–	0.44%	91
2021 Q2	$2.27M	Sell	9,300 -5,100	-35%	-$1.25M	0.47%	68
2021 Q1	$3.58M	Buy	14,400 +2,100	+17%	+$501K	0.74%	21
2020 Q4	$2.83M	Buy	12,300 +7,200	+141%	+$1.66M	0.74%	29
2020 Q3	$1.3M	Buy	+5,100	New	+$1.26M	0.34%	123
2020 Q2	–	Sell	-15,500	Closed	-$3.14M	–	265
2020 Q1	$3.14M	Buy	+15,500	New	+$3.39M	0.85%	10
2019 Q4	–	Sell	-5,250	Closed	-$1.02M	–	204
2019 Q3	$1.02M	Buy	5,250 +250	+5%	+$48K	0.29%	129
2019 Q2	$921K	Sell	5,000 -15,000	-75%	-$2.69M	0.26%	135
2019 Q1	$3.8M	Hold	20,000	–	–	0.93%	12
2018 Q4	$3.89M	Buy	+20,000	New	+$3.9M	0.94%	10
2016 Q4	–	Sell	-900	Closed	-$150K	–	190
2016 Q3	$150K	Hold	900	–	–	0.02%	114
2016 Q2	$137K	Hold	900	–	–	0.02%	127
2016 Q1	$135K	Hold	900	–	–	0.02%	147
2015 Q4	$146K	Sell	900 -39,100	-98%	-$6.15M	0.02%	142
2015 Q3	$5.53M	Buy	+40,000	New	+$6.31M	0.7%	57
2015 Q1	–	Sell	-25,000	Closed	-$3.98M	–	190
2014 Q4	$3.98M	Hold	25,000	–	–	0.4%	92
2014 Q3	$3.51M	Sell	25,000 -25,000	-50%	-$3.26M	0.3%	115
2014 Q2	$5.92M	Sell	50,000 -100,000	-67%	-$11.6M	0.45%	86
2014 Q1	$18.5M	Sell	150,000 -25,000	-14%	-$3.03M	1.39%	17
2013 Q4	$20M	Sell	175,000 -75,000	-30%	-$8.53M	1.42%	15
2013 Q3	$28M	Buy	250,000 +50,000	+25%	+$5.42M	1.54%	7
2013 Q2	$19.7M	Buy	+200,000	New	+$20.8M	0.9%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Hussman Strategic Advisors's AMGN Position: Q1 2026 in Review

Hussman Strategic Advisors reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $1.12M and leaving 5,250 shares worth $1.85M. The position accounts for 0.4% of the portfolio, ranked #119.

Hussman Strategic Advisors first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $28M in Q3 2013. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Hussman Strategic Advisors held 5,250 shares of Amgen worth $1.85M as of Q1 2026.
Hussman Strategic Advisors sold 3,150 Amgen shares in Q1 2026, an estimated $1.12M.
Amgen made up 0.4% of Hussman Strategic Advisors's portfolio in Q1 2026, its #119 holding.
Hussman Strategic Advisors first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
Hussman Strategic Advisors's Amgen position peaked at $28M in Q3 2013.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.